Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-16-151303

SVP & Chief Financial Officer sold 1,654 shares at $13.96 ($23,090)

From the SEC's structured data for this filing

Trades in this filing

Labrucherie Gil M · SVP & Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2016-11-16 Sale : show line 1 in the form −1,654 $13.96 $23,090 51,129 D
Open-market sales · 1,654 sh · avg $13.96 · $23,090
Loading xslF345X03/doc4.xml…